| Previous Close | 77.86 |
|---|---|
| Volume | 670,902 |
| Day's Range | 77.18 - 77.99 |
| 52-Week Range | 57.14 - 84.00 |
| Year-to-Date Return | 9.70% |
|---|---|
| 1-Year Return | 28.51% |
| 3-Year Annualized Return | -1.61% |
| 5-Year Annualized Return | 2.16% |
| Expense Ratio | 0.48 |
|---|---|
| Net Assets | $ 1,353 mil |
| Alpha | 0.18 |
| R-Squared | 0.43 |
| Dividend (Yield) | $0.00 (0.00%) |
| Avg. Market Cap | $ 17,871 mil |
| Beta | 0.66 |
| Price/Earnings | 34.08 |
| Ex-Dividend Date | NA |
| Turnover | 11.00 |
| Standard Deviation | 5.77 |
| Price/Book | 5.94 |
| Management Company | Barclays Global Fund Advisors |
| Administrator | Barclays Global Fund Advisors |
| Company of Name | % of Total | # of Shares Held |
|---|---|---|
| 1. Amgen | 11.06% | 2,987,363 |
| 2. Gilead Sciences Inc | 8.41% | 2,937,446 |
| 3. Teva Pharmaceutical Industries Ltd | 7.27% | 2,340,852 |
| 4. Celgene Corp | 6.45% | 1,877,067 |
| 5. Vertex Pharma | 3.78% | 1,624,084 |
| 6. Biogen Idec Inc | 3.23% | 1,041,635 |
| 7. Genzyme Corp | 3.08% | 882,929 |
| 8. Illumina Inc | 2.77% | 1,059,883 |
| 9. Alexion Pharm | 2.36% | 862,506 |
| 10. Life Technologies Corp | 2.05% | 716,276 |
| % of Total Holdings | 50.46% |